Ergoteles’s Cartesian Growth Corp II RENE Stock Holding History

Ergoteles’s Portfolio RENE Stock Details RENE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-25,000	Closed	-$262K	–	1429
2023 Q1	$262K	Sell	25,000 -5,000	-17%	-$51.9K	0.01%	931
2022 Q4	$308K	Hold	30,000	–	–	0.01%	900
2022 Q3	$300K	Buy	+30,000	New	+$301K	0.01%	975

Other funds holding RENE

Cantor Fitzgerald New York $6.78B AUM 29.01% 1-Year Est. Return

Calamos Advisors Naperville, Illinois $28.2B AUM 21.78% 1-Year Est. Return

WCMNY

Westchester Capital Management (New York) Valhalla, New York $2.21B AUM 26.02% 1-Year Est. Return

FTCM

First Trust Capital Management Chicago, Illinois $1.9B AUM 58.39% 1-Year Est. Return

Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return

KIM LLC Wichita, Kansas $976M AUM 0.91% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.94% 1-Year Est. Return

LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return

PAMP

Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return

Ergoteles's RENE Position: Q2 2023 in Review

Ergoteles sold out of Cartesian Growth Corp II (RENE) in Q2 2023, closing a stake of 25,000 shares — an estimated $262K sold.

Ergoteles first reported a position in RENE in Q3 2022 and held it in 3 quarters. The position peaked at $308K in Q4 2022. 50 funds tracked by Wall St. Rank hold RENE as of Q2 2023.

Ergoteles reported no remaining Cartesian Growth Corp II position as of Q2 2023 after selling out during the quarter.
Ergoteles sold 25,000 Cartesian Growth Corp II shares in Q2 2023, an estimated $262K.
Ergoteles first reported a position in Cartesian Growth Corp II in Q3 2022 and held it in 3 quarters.
Ergoteles's Cartesian Growth Corp II position peaked at $308K in Q4 2022.
50 funds tracked by Wall St. Rank held Cartesian Growth Corp II as of Q2 2023.

Based on Ergoteles's 13F filing for Q2 2023, filed 14 Aug 2023.